300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Sudan
Cameroon
Guernsey
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
United Kingdom
Germany
India
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Bangladesh
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Downing Ventures, VC Fund

Downing Ventures

VC Fund

London, United Kingdom

Downing Ventures is a division of Downing LLP. They invest venture capital into early and growth stage technology businesses. Our belief is that technology now forms an integral part of the everyday lives of consumers, corporations and governments. Further, they believe that they are now experiencing the benefits of the second wave of technologydevelopment, which is now based on sound infrastructure. Investing into this trend, they look for: Visionary entrepreneurs, with the ability to execute as well as dream. Large (potential) addressable markets. Distinct product / service advantages. Limited adoption risk for customers. They seek to invest 250,000 to 5 million per company. They will invest in seed-stage deals and Series A deals, and then look to continue to support those companies through phases of subsequent growth. Fundamentally, they back entrepreneurs. They are supportive, hopefully helpful, investors.

Total investments:
134
Last investment:
Lead investor:
32%
Fund size:
$2.8M
Last fund:

Last updated:

Industries Downing Ventures invests in

SoftwareHealth CareInformation TechnologyArtificial IntelligenceBiotechnology

Stages Downing Ventures invests in

Series ASeedFunding RoundSeries BVenture - Series Unknown

Countries Downing Ventures invests in

United KingdomUnited StatesIsrael

Round sizes

Seed $550k–$4.7MSeries A $3.2M–$13M

Contacts

NameEmailPhoneSocials
See all 12 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$550k–$4.7M
Series A
$3.2M–$13M

Investment Focus

Industry

  • Software 22 (16%)
  • Health Care 17 (13%)
  • Information Technology 14 (10%)
  • Artificial Intelligence 12 (9%)
  • Biotechnology 10 (7%)
See all 145 industries →

Stage

  • Series A 29 (22%)
  • Seed 28 (21%)
  • Funding Round 27 (20%)
  • Series B 11 (8%)
  • Venture - Series Unknown 8 (6%)
See all 8 stages →

Country

  • United Kingdom 72 (54%)
  • United States 8 (6%)
  • Israel 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Kostas Manolis
Kostas Manolis Partner and Head of Unquoted Investments
Partner and Head of Unquoted Investments Total investments: 2
Find email
Mike Kennedy
Mike Kennedy Ventures Adviser - Downing Ventures
Ventures Adviser - Downing Ventures Total investments: 3
Find email
Nick Lewis
Nick Lewis Founding Partner, Investment Committee Member & Chairman
Founding Partner, Investment Committee Member & Chairman Total investments: 0 Find email
Sophie Andre
Sophie Andre Portfolio and Operations Manager
Portfolio and Operations Manager Total investments: 0
Find email
Chris Allner
Chris Allner Partner
Partner Total investments: 0
Find email
See all 12 team members →

Investments

CompanyDescriptionRoundLinks
TidalSense TidalSense
CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath. $3.2M / Seed / May 16, 2023
Qkine Qkine
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-upchallenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company. $5.2M / Series B / Dec 15, 2022
FundamentalVR FundamentalVR
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. $20M / Series B / Aug 11, 2022
BBC Maestro BBC Maestro
BBC Maestro is a streaming platform that was developed to teach and inspire individuals to explore their creativity. Anyone can master a wide range of disciplines and follow in the footsteps of specialists respected all over the world by using pre-recorded classes and complete course notes. Seed / Aug 01, 2022
Distributed Distributed
Distributed is a software development company that develops an on-demand Elastic Team that allows getting things done faster. Through the Distributed platform, clients can work with fully managed, globally distributed teams of highly skilled software engineers allowing them to build and maintain software faster, more efficiently, cost-effectively,and with more visibility than ever before. The company was founded in 2017 and is based in London, England. $10.5M / Jun 30, 2022
Distributed Distributed
Distributed is a software development company that develops an on-demand Elastic Team that allows getting things done faster. Through the Distributed platform, clients can work with fully managed, globally distributed teams of highly skilled software engineers allowing them to build and maintain software faster, more efficiently, cost-effectively,and with more visibility than ever before. The company was founded in 2017 and is based in London, England. $9.7M / Series A / Jun 29, 2022
Glisser Glisser
Glisser is an award-winning tech platform powering unique company event experiences, anywhere. Our best-in-class virtual and hybrid event tools give planners the power to wow and make every event count. Clients include KPMG, Pfizer, Informa, Facebook, Uber, and many more.The platform is developed by event industry veterans to go beyond basicvideo and screen sharing tech, to create inspiring, high participation events of any size, whether it’s a highly focused interactive training session or communicating to 150,000 attendees across the globe. Venture - Series Unknown / May 17, 2022
Dragonfly AI Dragonfly AI
Dragonfly AI is a predictive heatmap that shows exactly what catches the audience's attention first across any content, allow us to make data-informed decisions without holding business down. Get real-time insight into what genuinely catches their customers' attention. Predictive analytics can help us increase efficiency throughout thedesign cycle. Improve the success rate across all channels. Increase their ROI by increasing their share of attention across channels. $3.9M / Series A / Apr 11, 2022
Virtuoso Virtuoso
Virtuoso uses artificial intelligence, machine learning, and robotic process automation to run a test automation tool that gives the speed of codeless paired with the power of scripted test steps. They develop codeless test automation software without slowing down the development process. They provide functional UI testing and continuous testingsolutions. $13.3M / Series A / Nov 15, 2021
Closed Loop Medicine Closed Loop Medicine
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and lifescientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development. $16.6M / Series A / Nov 03, 2021
See all 134 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Sudan
Cameroon
Guernsey
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
United Kingdom
Germany
India
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Bangladesh
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Downing Ventures invest in?

Downing Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Series A and Seed stage. Most of the 134 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Downing Ventures's check size?

Downing Ventures typically joins rounds of $550k–$4.7M at Seed and $3.2M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Downing Ventures participates in.

How do I contact Downing Ventures?

Public channels for Downing Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Downing Ventures?

The team at Downing Ventures includes Kostas Manolis (Partner and Head of Unquoted Investments), Mike Kennedy (Ventures Adviser - Downing Ventures) and Nick Lewis (Founding Partner, Investment Committee Member & Chairman), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Downing Ventures Downing Ventures Find emails